Quick Answer
ADMA BIOLOGICS, INC. reported Long Term Debt of $69.33 million for the year ending 2025.
- ADMA BIOLOGICS, INC. showed a decrease of -4.2% in Long Term Debt from 2024 to 2025.
- This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2016 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $1.79 million | Q3 2017: $1.79 million | Q1 2018: $2.76 million | Q2 2018: $2.76 million | Q3 2018: $2.76 million | Q1 2019: $0.00 | Q2 2019: $0.00 | Q3 2019: $0.00 | Q3 2025: $70.08 million.
- Over the full 6 years of available data (2016 to 2025), ADMA BIOLOGICS, INC.'s Long Term Debt has grown by 3,773.2%.
- Historical annual values: Fiscal year 2025: $69.33 million | Fiscal year 2024: $72.34 million | Fiscal year 2019: $0.00 | Fiscal year 2018: $2.76 million | Fiscal year 2017: $2.76 million | Fiscal year 2016: $1.79 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: